Key molecular pathways implicated in FSGS include the activation of the renin-angiotensin-aldosterone system, aberrant TGF-β signaling, and increased oxidative stress, which contributes to podocyte injury and glomerular sclerosis (12, 13). The gene discussed is TGFB1; the disease is focal segmental glomerulosclerosis.